Pevonedistat and Azacitidine in MDS or MDS/MPN Patients Who Fail Primary Therapy With DNA Methyl Transferase Inhibitors
Clinical trial NCT03238248 · COMPLETED
Trial details
- NCT number
- NCT03238248
- Sponsor
- Vanderbilt-Ingram Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-08-07
- Primary completion
- 2022-09-30
- Enrollment
- 71
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.